Work

MM-349: Teclistamab Plus Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma: Analysis of MajesTEC-3 Based on Cytogenetic and Functional Risk

Year: 2026
Type: conference-abstract
Institutions: University of Washington, Fred Hutch Cancer Center, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Emory University, Winship Cancer Institute, Consejo Superior de Investigaciones Científicas, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, University of Calgary, Centre Hospitalier Universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Université de Toulouse, Peking University People's Hospital, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital, Hospital Privado, Hôpital de Jolimont, São Germano Oncologia, Rigshospitalet, Odense University Hospital, University Hospital Carl Gustav Carus, Technische Universität Dresden, University of Tübingen, Korea University, National and Kapodistrian University of Athens, Korea University Medical Center, Istituto di Ematologia di Bologna, University of Bologna, Hyogo Medical University Hospital, Samsung Medical Center, Sungkyunkwan University, Isala, St. Antonius Ziekenhuis, University Clinical Centre, Gdańsk Medical University, Sahlgrenska University Hospital, Blackpool Victoria Hospital, Blackpool Teaching Hospitals NHS Foundation Trust, Stanford Medicine, Stanford University, Clinica Universidad de Navarra, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre, Spanish National Cancer Research Centre, Hospital Universitario 12 De Octubre, Memorial Sloan Kettering Cancer Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Université de Lille, Centre Hospitalier Universitaire de Lille, Centro de Investigación Médica Aplicada, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Johnson & Johnson (United States), Johnson & Johnson (United Kingdom), University of Alabama at Birmingham
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7204687703
Cites:
Cited by:
Related to: 10